Skip to main content

Elevance Health Inc(ELV-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low281.50
Day High289.96
Open:286.50
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Elevance Health Inc

Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV), Veeva Systems (VEEV) and Janux Therapeutics Inc (JANX)
Tipranks
Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Janux Therapeutics Inc (JANX)
Motley Fool
This Fund Sold $3 Million in OneMain Stock Last Quarter, but Here's Why It Still Seems Bullish on the Lender
Motley Fool
This $101 Million Bet Boosts Millrose Stake as Shares Jump 38% in a Year
Motley Fool
What's Behind This Nearly $70 Million Exit From Kinetik Stock?
Tipranks
Barclays Reaffirms Their Buy Rating on Elevance Health (ELV)
Tipranks
Elevance Health Restructures Leadership, Reaffirms 2026 Guidance
StockStory
1 S&P 500 Stock for Long-Term Investors and 2 We Ignore
AOS
Zacks Investment Research
UnitedHealthcare Under Pressure: Can UNH's Core Business Rebound?
UnitedHealthcare Under Pressure: Can UNH's Core Business Rebound?
StockStory
3 Large-Cap Stocks with Solid Fundamentals
PYPL
StockStory
1 Profitable Stock to Target This Week and 2 We Avoid
FAST
StockStory
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
ELV
StockStory
2 Reasons to Like ELV (and 1 Not So Much)
ELV
Zacks Investment Research
Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength
Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength
Zacks Investment Research
Will Declining Medical Membership Affect Humana's Q4 Earnings?
Will Declining Medical Membership Affect Humana's Q4 Earnings?
Zacks Investment Research
Ensign Group Q4 Earnings Beat Estimates on Growing Occupancy
Ensign Group Q4 Earnings Beat Estimates on Growing Occupancy
StockStory
5 Revealing Analyst Questions From Elevance Health’s Q4 Earnings Call
ELV
Zacks Investment Research
Can Centene's Q4 Earnings Escape Membership & Cost Headwinds?
Can Centene's Q4 Earnings Escape Membership & Cost Headwinds?
Tipranks
Truist Financial Sticks to Its Buy Rating for Elevance Health (ELV)
Tipranks
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Elevance Health (ELV)
Tipranks
Jefferies Remains a Buy on Elevance Health (ELV)
Tipranks
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Halozyme (HALO) and Elevance Health (ELV)
Tipranks
Analysts Offer Insights on Healthcare Companies: Corvus Pharmaceuticals (CRVS), Elevance Health (ELV) and Universal Health (UHS)
Tipranks
Barclays Remains a Buy on Elevance Health (ELV)
Tipranks
Analysts Are Bullish on These Healthcare Stocks: Bristol-Myers Squibb (BMY), HCA Healthcare (HCA)
Tipranks
Elevance Health Earnings Call Flags Reset Before Rebound
Zacks Investment Research
Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results
Healthcare ETFs in Focus as UnitedHealth Rises 4% Post Mixed Q4 Results
Tipranks
Truist Financial Reaffirms Their Buy Rating on Elevance Health (ELV)
StockStory
ELV Q4 Deep Dive: Margin Pressures and Membership Shifts Shape 2026 Outlook
ELV
Motley Fool
Elevance Health ELV Q4 2025 Earnings Transcript
Tipranks
Elevance Health (ELV) Receives a Buy from Bernstein
StockStory
Elevance Health (NYSE:ELV) Reports Q4 CY2025 In Line With Expectations But Stock Drops
ELV

Profile

Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.